Selective targeting of HIV infected clones by cognate peptide stimulation and antiproliferative drugs

Filippo Dragoni; Joel Sop; Isha Gurumurthy; Tyler P. Beckey; Kellie N. Smith; Francesco R. Simonetti; Joel N. Blankson

doi:10.1172/JCI197266

Selective targeting of HIV infected clones by cognate peptide stimulation and antiproliferative drugs

Filippo Dragoni,¹ Joel Sop,¹ Isha Gurumurthy,² Tyler P. Beckey,¹ Kellie N. Smith,² Francesco R. Simonetti,¹ and Joel N. Blankson¹

Published October 21, 2025 - More info

View PDF

Abstract

Clonal expansion of HIV infected CD4+ T cells is a barrier to HIV eradication. We previously described a marked reduction in the frequency of the most clonally expanded infected CD4+ T cells in an individual with elite control (ES24) after initiating chemoradiation for metastatic lung cancer with a regimen that included paclitaxel and carboplatin. We tested the hypothesis that this phenomenon was due to a higher susceptibility to the chemotherapeutic drugs of CD4+ T cell clones that were sustained by proliferation. We studied a CD4+ T cell clone with replication-competent provirus integrated into the ZNF721 gene, termed ZNF721i. We stimulated the clone with its cognate peptide and then exposed the cells to paclitaxel and/or carboplatin or the antiproliferative drug, mycophenolate mofetil. While treatment of cells with the cognate peptide alone led to a marked expansion of the ZNF721i clone, treatment with the cognate peptide followed by culture with either paclitaxel or mycophenolate mofetil abrogated this process. The drugs did not affect the proliferation of other CD4+ T cell clones that were not specific for the cognate peptide. This strategy of antigen-specific stimulation followed by treatment with an antiproliferative agent may lead to the selective elimination of clonally expanded HIV-infected cells.

Selective targeting of HIV infected clones by cognate peptide stimulation and antiproliferative drugs

Filippo Dragoni,¹ Joel Sop,¹ Isha Gurumurthy,² Tyler P. Beckey,¹ Kellie N. Smith,² Francesco R. Simonetti,¹ and Joel N. Blankson¹

Article tools

Metrics

Go to

Selective targeting of HIV infected clones by cognate peptide stimulation and antiproliferative drugs

Filippo Dragoni,1 Joel Sop,1 Isha Gurumurthy,2 Tyler P. Beckey,1 Kellie N. Smith,2 Francesco R. Simonetti,1 and Joel N. Blankson1

Article tools

Metrics

Go to

Sign up for email alerts

Filippo Dragoni,¹ Joel Sop,¹ Isha Gurumurthy,² Tyler P. Beckey,¹ Kellie N. Smith,² Francesco R. Simonetti,¹ and Joel N. Blankson¹